MeSH D003015 - clostridium infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Sandoz | Tigecycline | Tigecycline |  | 2015-05-27 |  |  |
| Merck & Co | Bezlotoxumab | Zinplava |  | 2016-10-21 |  |  |
| Pfizer | Tigecycline | Tygacil |  | 2006-04-24 | $202 M | Q4/18-Q3/21 |
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
Phase 1
40%2/5
Phase 2
89%8/9
Phase 3
68%13/19
Approved: 9Overall Success rate: 24%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use